An international pilot study of oncology physicians' opinions and practices on complementary and alternative medicine (CAM)

Integrative Cancer Therapies

Volumn 7, Issue 2, 2008, Pages 70-75

  Lee, Richard T ^a,b,e   Hlubocky, Fay J ^a   Hu, Je Jen ^c   Stafford, Randall S ^c,d   Daugherty, Christopher K ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

Author keywords

Complementary and alternative medicine; Oncologists; Opinions; Practice patterns

Indexed keywords

ADULT; ALTERNATIVE MEDICINE; ARTICLE; CANCER THERAPY; CHINA; CLINICAL PRACTICE; FEMALE; HUMAN; MALE; PILOT STUDY; PREVALENCE; PRIORITY JOURNAL; SELF REPORT; TAIWAN; UNITED STATES;

ADULT; ATTITUDE OF HEALTH PERSONNEL; CALIFORNIA; CHINA; COMPLEMENTARY THERAPIES; FEMALE; HUMANS; ILLINOIS; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; NEOPLASMS; PHYSICIAN'S PRACTICE PATTERNS; PILOT PROJECTS; QUESTIONNAIRES; TAIWAN;

EID: 44949102561     PISSN: 15347354     EISSN: 1552695X     Source Type: Journal    
DOI: 10.1177/1534735408319059     Document Type: Article

References (34)

1. Munstedt K., Entezami A., Wartenberg A., et al. The attitudes of physicians and oncologists towards unconventional cancer therapies (UCT). Eur J Cancer. 2000 ; 36: 2090-2095.
2. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998 ; 280: 1569-1575.
3. Barnes PM, Powell-Griner E., McFann K., et al. Complementary and alternative medicine use among adults: United States, 2002. Adv Data. 2004 ; 1-19.
4. Ernst E., Cassileth B. The prevalence of complementary/ alternative medicine in cancer. Cancer. 1998 ; 83: 777-782.
5. Richardson MA, Sanders T., Palmer JL, et al. Complementary/ alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol. 2000 ; 18: 2505-2514.
6. Liu JM, Chu HC, Chin YH, et al. Cross-sectional study of use of alternative medicines in Chinese cancer patients. Jpn J Clin Oncol. 1997 ; 27: 37-41.
7. Hyodo I., Amano N., Eguchi K., et al. Nationwide survey on complementary and alternative medicine in cancer patients in Japan. J Clin Oncol. 2005 ; 23: 2645-54.
8. Boon HS, Olatunde F., Zick SM Trends in complementary/ alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005. BMC Womens Health. 2007 ; 7: 4.
9. Soignet SL, Maslak P., Wang ZG, et al. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med. 1998 ; 339: 1341-1348.
10. Antman KH Introduction: the history of arsenic trioxide in cancer therapy. Oncologist. 2001 ; 6 (Suppl 2). 1-2.
11. Shen ZX, Chen GQ, Ni JH, et al. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood. 1997 ; 89: 3354-3360.
12. Ezzo J., Vickers A., Richardson MA, et al. Acupuncture-point stimulation for chemotherapy-induced nausea and vomiting. J Clin Oncol. 2005 ; 23: 7188-7198.
13. Bardia A., Barton DL, Prokop LJ, et al. Efficacy of complementary and alternative medicine therapies in relieving cancer pain: a systematic review. J Clin Oncol. 2006 ; 24: 5457-5464.
14. Meijerman I., Beijnen JH, Schellens JH Herb-drug interactions in oncology: focus on mechanisms of induction. Oncologist. 2006 ; 11: 742-752.
15. Sparreboom A., Cox MC, Acharya MR, et al. Herbal remedies in the United States: potential adverse interactions with anticancer agents. J Clin Oncol. 2004 ; 22: 2489-2503.
16. McCune JS, Hatfield AJ, Blackburn AA, et al. Potential of chemotherapy-herb interactions in adult cancer patients. Support Care Cancer. 2004 ; 12: 454-462.
17. Ernst E. Toxic heavy metals and undeclared drugs in Asian herbal medicines. Trends Pharmacol Sci. 2002 ; 23: 136-139.
18. Ernst E., Thompson Coon J. Heavy metals in traditional Chinese medicines: a systematic review. Clin Pharmacol Ther. 2001 ; 70: 497-504.
19. Clouatre D. Kava kava: examining new reports of toxicity. Toxicol Lett. 2003 ; 150: 85-96.
20. Risberg T., Vickers A., Bremnes RM, et al. Does use of alternative medicine predict survival from cancer ? Eur J Cancer. 2003 ; 39: 372-377.
21. Sugarman J., Burk L. Physicians' Ethical Obligations Regarding Alternative Medicine. JAMA. 1998 ; 280: 1623-1625.
22. Hesketh T., Zhu WX Health in China. Traditional Chinese medicine: one country, two systems. BMJ. 1997 ; 315: 115-117.
23. Get the facts: What is complementary and alternative medicine? National Institutes of Health-National Center for Complementary and Alternative Medicine Website, 2002.
24. McQuade-Shankman J., ZhiQiang M., Zhen C., et al. Utilization of and attitudes towards Traditional Chinese Medicine therapies in a Chinese cancer hospital. Presented at Society for Integrative Oncology Annual Meeting. Boston, MA, November 9-11, 2006.
25. Hyodo I., Eguchi K., Nishina T., et al. Perceptions and attitudes of clinical oncologists on complementary and alternative medicine: a nationwide survey in Japan. Cancer. 2003 ; 97: 2861-2868.
26. Crocetti E., Crotti N., Montella M., et al. Complementary medicine and oncologists' attitudes: a survey in Italy. Tumori. 1996 ; 82: 539-542.
27. Corbin Winslow L., Shapiro H. Physicians want education about complementary and alternative medicine to enhance communication with their patients. Arch Intern Med. 2002 ; 162: 1176-1181.
28. Robinson A., McGrail MR Disclosure of CAM use to medical practitioners: a review of qualitative and quantitative studies. Complement Ther Med. 2004 ; 12: 90-98.
29. Richardson MA, Straus SE Complementary and alternative medicine: opportunities and challenges for cancer management and research. Semin Oncol. 2002 ; 29: 531-545.
30. Richardson MA, Masse LC, Nanny K., et al. Discrepant views of oncologists and cancer patients on complementary/alternative medicine. Support Care Cancer. 2004 ; 12: 797-804.
31. Tasaki K., Maskarinec G., Shumay DM, et al. Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients' perspectives. Psychooncology. 2002 ; 11: 212-220.
32. Aarp, Nccam. Complementary and Alternative Medicine: What People 50 and Older Are Using and Discussing with Their Physicians, 2007
33. Nccam. Time to Talk. Available at: http://nccam.nih.gov/timetotalk/. Accessed 2007.
34. Dy GK, Bekele L., Hanson LJ, et al. Complementary and alternative medicine use by patients enrolled onto phase I clinical trials. J Clin Oncol. 2004 ; 22: 4810-4815.